Primarily focused upon the provision of sales, marketing and logistics operations to the acute care sector, the company grew into a specialist supplier of leading-edge healthcare solutions, premium consumables, medical devices, equipment and services to all healthcare providers.Â
The same family ethos upon which HC21 was founded still exists today; something it takes immense pride in. Partners are welcomed into the Healthcare 21 family, enabling the sharing of expertise and knowledge as one organisation.Â
The acquisition of EuroMed, opens new opportunities in the wholesale pharmaceutical sector.
Both companies share a vision of collaboration and quality, making EuroMed a natural fit into HC21’s network of healthcare partners. In addition, EuroMed’s expertise within medical devices and diagnostics enables expansion into previously untapped markets.
HC21 expands primary care portfolio further through the acquisition of specialist Tools for Living. The move also develops new leads and connections within the primary care sector.
This presented HC21 with an opportunity to mirror what it was doing in Ireland for the UK market and established the UK arm in Leeds as part of its ambition to be one of the largest medical suppliers in Europe.
After spending €1.2 million on a new decontamination and recycling facility in Annacotty, Co Limerick, the Irish Decontamination business represented a diversification of service offering.
HC21 has been working with the Surgical Stapling and Critical Care portfolio of the world’s largest medical device company, Medtronic, since 2003. More than fifteen years on, and the partnership has grown significantly, encompassing 5,350 individual product codes and delivering in-market annual revenues of more than €25M, across both Ireland and the United Kingdom.
The Healthcare 21 partnership with Allergan extends across four European countries and five brands. In 2015, HC21 took over the LifeCell portfolio across the UK and Ireland before extending this partnership to Germany and Austria, setting up a dedicated customer service and logistics centre, in Wiesbaden, Germany. In 2017, Allergan transferred its substantive Natrelle® breast implant business to Healthcare 21 in Germany, and then to its operations in the UK and Ireland the following year.
The move that saw the acquisition of Aquilant, a distributor of specialist medical, pharmaceutical and scientific products and services was hailed as the most significant step forward in HC21’s history. It helped to accelerate HC21’s drive to become a pan European, best in class provider of specialist sales, marketing and service solutions for world leading supplier partners.
It not only confirmed HC21’s strategy for growth and expansion, but also a commitment to the highly innovative MedTech and Diagnostic Technical services industry.
Early 2020 saw the acquisition of Cardio Solutions, one of the UK’s foremost independent distributors of cardiothoracic, vascular, electrophysiology and interventional cardiology products through the UK and Ireland.
The Yorkshire business had developed strong partnerships with the world’s leading suppliers of cardiac implantable devices, consumables and surgical instrumentation to provide a complete solution package for open, minimally invasive and port access surgery.
It marked the third acquisition of leading, mainland UK businesses in less than three years, and saw HC21 virtually triple in size.